非肿瘤相关风险评分:改善结直肠癌肝转移肝切除预后预测的新工具
研究基于美国两家机构1205例训练队列,开发了由碱性磷酸酶、白蛋白和平均红细胞体积构成的非肿瘤相关预后评分,并在亚洲1307例和欧洲1058例外部验证队列中验证。该评分外部验证C指数为0.58,与三种常用肿瘤相关评分相当,联合应用可将C指数提升至0.60-0.64并改善重分类。
要点
- 非肿瘤相关预后评分由碱性磷酸酶、白蛋白和平均红细胞体积构成。
- 外部验证C指数0.58,与Fong 0.53、m-CRS 0.55、GAME 0.58相当。
- 联合肿瘤相关评分后C指数提升至0.60-0.64,重分类改善21.2%-42.7%。
核心结论
- 非肿瘤相关预后信息可能有助于改善结直肠癌肝转移切除后的预后分层。
- 非肿瘤相关预后评分可与肿瘤相关预后工具联合使用以增强预后分层。
研究设计与样本
- 训练队列来自2家美国机构,共1205例。
- 外部验证队列来自5家亚洲机构1307例和3家欧洲机构1058例。
- 评估指标为Harrell C指数和净重分类改善,并与Fong、m-CRS、GAME三种肿瘤相关评分比较。
主要发现
- 碱性磷酸酶(HR 1.43;95%CI 1.11-1.84)、白蛋白(HR 0.71;95%CI 0.57-0.89)、平均红细胞体积(每对数单位HR 19.0;95%CI 4.79-75.0)均独立与结直肠癌肝转移切除后死亡风险相关(均P<.05)。
- 非肿瘤相关预后评分公式为(2.942×平均红细胞体积+0.399×碱性磷酸酶-0.339×白蛋白-12)×10,中位数16,范围1-30。
- 外部验证队列中非肿瘤相关预后评分C指数=0.58,Fong评分C指数=0.53,m-CRS C指数=0.55,GAME评分C指数=0.58。
- 联合评分在全研究队列中C指数:非肿瘤评分+Fong=0.60,非肿瘤评分+m-CRS=0.61,非肿瘤评分+GAME=0.64。
- 重分类改善分别为42.5%(联合Fong)、42.7%(联合m-CRS)、21.2%(联合GAME)。
临床怎么用
- 非肿瘤相关预后评分可能作为肿瘤相关预后工具的补充,用于结直肠癌肝转移切除后的预后分层。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prognostic stratification of patients with colorectal cancer liver metastasis based solely on tumor-related factors has only moderate discriminatory ability. We hypothesized that the inclusion of nontumor related factors can improve prediction of long-term prognosis of patients with colorectal cancer liver metastasis. METHODS: Nontumor related laboratory markers were assessed utilizing a training cohort from 2 U.S. institutions (n = 1,205). Factors independently associated with prognosis were used to develop a nontumor related prognostic score. The discriminatory ability, assessed by Harrell's C-statistics (C-index) and net reclassification improvement, was validated and compared with 3 commonly used tumor-related clinical risk scores: Fong clinical risk scores, m-clinical risk scores, and Genetic and Morphological Evaluation (GAME) score in an external validation cohort from 5 Asian (n = 1,307) and 3 European (n = 1,058) institutions. The discriminatory ability of nontumor related prognostic score combined with each of these 3 tumor-related prognostic scores was also estimated. RESULTS: Alkaline phosphatase (hazard ratio 1.43; 95% confidence interval, 1.11-1.84), albumin (hazard ratio 0.71; 95% confidence interval, 0.57-0.89), and mean corpuscular volume (hazard ratio 19.0, per log unit; 95% confidence interval, 4.79-75.0) were each independently associated with increased risk of death after resection of colorectal cancer liver metastasis (all P < .05). In turn, alkaline phosphatase, albumin, and mean corpuscular volume were combined to form a nontumor related prognostic score (2.942 × mean corpuscular volume + 0.399 × alkaline phosphatase-0.339 × albumin-12) × 10 (median, 16; range, 1-30). The nontumor related prognostic score had good-to-modest discriminatory ability in the external cohort (C-index = 0.58), which was comparable to the 3 established tumor-related prognostic scores (C-index: Fong clinical risk scores, 0.53, m-clinical risk scores, 0.55, GAME, 0.58). The addition of the nontumor related prognostic score to the tumor-related prognostic scores enhanced the discriminatory ability in the entire study cohort (C-index: nontumor related score+Fong, 0.60, nontumor related score+m-clinical risk scores, 0.61, nontumor related score+GAME, 0.64), as well reclassification improvement (42.5, 42.7%, and 21.2%, respectively). CONCLUSION: Nontumor related prognostic information may help improve the prognostic stratification of patients after resection of colorectal cancer liver metastasis. The nontumor related prognostic score may be combined with tumor-related prognostic tools to enhance prognostic stratification of patients with colorectal cancer liver metastasis.
引用
- Sasaki K, Margonis GA, Moro A, et al. Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastases. Surgery. 2022. PMID: 35221105. doi:10.1016/j.surg.2022.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。